COLON CANCER
Clinical trials for COLON CANCER explained in plain language.
Never miss a new study
Get alerted when new COLON CANCER trials appear
Sign up with your email to follow new studies for COLON CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cancer drug shows promise in early trial for advanced tumors
Disease control TerminatedThis early-phase study tested a new drug called PHN-010 in 26 people with advanced solid tumors (lung, colon, endometrial, ovarian, or cervical cancer) that had already been treated with at least one prior therapy. The drug is an antibody-drug conjugate designed to deliver a toxi…
Matched conditions: COLON CANCER
Phase: PHASE1 • Sponsor: Pheon Therapeutics • Aim: Disease control
Last updated May 12, 2026 13:39 UTC
-
New cancer drug AUR106 tested in advanced tumors – early results
Disease control TerminatedThis early-stage study tested a new drug called AUR106 in 21 adults with advanced solid tumors like lung, stomach, bladder, kidney, colon, or esophageal cancer that had come back or spread. The main goal was to find the safest dose and understand how the drug works in the body. T…
Matched conditions: COLON CANCER
Phase: PHASE1 • Sponsor: Aurigene Discovery Technologies Limited • Aim: Disease control
Last updated May 11, 2026 20:51 UTC
-
New cancer pill tested, but study stopped early
Disease control TerminatedThis early-stage study tested an experimental oral drug called ATX-559 in 17 people with advanced solid tumors that had stopped responding to standard treatments. The main goal was to find a safe dose and understand side effects. The study was terminated early, so results are lim…
Matched conditions: COLON CANCER
Phase: PHASE1 • Sponsor: Accent Therapeutics • Aim: Disease control
Last updated May 07, 2026 18:40 UTC